JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, published by WILEY, is a leading journal in the field of biomaterials and biomedical engineering, showcasing cutting-edge research that bridges the gap between material science and healthcare applications. With a robust 2023 impact factor reflecting its high-quality contributions, this journal is classified in the Q2 quartile for Biomaterials, Biomedical Engineering, and Ceramics and Composites, while achieving an impressive Q1 ranking in Metals and Alloys. The journal caters to a diverse readership, including researchers, professionals, and students, aiming to facilitate innovation and advancements in biocompatible materials and their applications in medical devices and tissue engineering. Access options for readers are available, ensuring the latest studies and findings are readily accessible to all stakeholders in this dynamic field. As it progresses towards its 2024 target, the JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A continues to be an essential resource for anyone involved in the development and application of biomedical materials.

IRBM, published by Elsevier Science Inc, stands at the forefront of research in the domains of Biomedical Engineering and Biophysics, boasting impressively high rankings with a Q1 category in both fields according to the 2023 evaluations. With an effective focus on cutting-edge innovations and methodologies, IRBM provides a vital platform for researchers, professionals, and students alike seeking to disseminate and access groundbreaking findings and developments. Its strong presence in the Scopus database, with ranks of #12 in Biochemistry, Genetics and Molecular Biology and #42 in Biomedical Engineering, places it in the top percentile of impactful journals in the field, making it a crucial resource for advancing knowledge and fostering collaboration. While the journal maintains a traditional subscription model, it continues to attract a diverse readership eager for insightful studies and reviews that push the boundaries of science and engineering. With a projected convergence of years extending to 2024, IRBM promises to remain a significant contributor to the ongoing dialogue in the life sciences.

ANNALS OF BIOMEDICAL ENGINEERING is a premier journal in the field of biomedical engineering, published by Springer. Established in 1972, this journal has become a vital resource for researchers, professionals, and students engaged in the rapidly evolving domain of biomedical technology. With a commendable impact factor and ranked in the 76th percentile among its peers as per Scopus, it exemplifies excellence in disseminating critical research findings. The journal covers a broad scope of topics related to the integration of engineering principles with medical and biological sciences, facilitating innovations that enhance healthcare outcomes. Although open access is not offered in this journal, it remains an essential platform for scholarly communication, contributing to the continuous advancement of knowledge in biomedical engineering. ANNALS OF BIOMEDICAL ENGINEERING is not only a bridge for academics to share groundbreaking research but also an influential guide for practical applications in medicine and health technologies, making it a fundamental publication for its readership.

Computer Methods in Biomechanics and Biomedical Engineering - Imaging and Visualization is a prominent academic journal published by Taylor & Francis Ltd, dedicated to the intersection of computational methods and biomedical engineering. With an ISSN of 2168-1163 and an E-ISSN of 2168-1171, the journal has become a crucial resource for researchers and professionals exploring innovative imaging and visualization techniques in healthcare. Covering a broad spectrum of topics, it aims to facilitate the advancement of knowledge in areas such as biomechanics, computational mechanics, and medical imaging. Holding a strong position in various Scopus rankings, including Q2 in Computational Mechanics, it offers valuable insights that foster interdisciplinary collaboration. Although it is not an open-access journal, researchers can access its rich repository of knowledge, which is instrumental in shaping future advancements in biomedical applications. The journal’s commitment to quality and relevance ensures that it remains an authoritative source for emerging trends and methodologies within the field, serving as a vital tool for academia and industry practitioners alike.

Cardiovascular Engineering and Technology, published by SPRINGER, stands as a prominent journal in the fields of Biomedical Engineering and Cardiology. With an ISSN of 1869-408X, this journal bridges the gap between engineering innovation and cardiovascular health by exploring the latest advancements pertinent to cardiovascular technologies and therapies. The journal, currently in its converged years from 2010 to 2024, holds important positions in Quartile 3 of both Biomedical Engineering and Cardiology and Cardiovascular Medicine categories, highlighting its relevance and influence in these domains. Ranked in the 59th percentile for Cardiology and 42nd percentile for Biomedical Engineering, the journal is a valuable resource for researchers, professionals, and students keen on understanding the intersection of engineering solutions and cardiovascular medicine. Although the journal is not open access, it remains highly regarded for its rigorous peer-reviewed content that contributes to the advancement of technology in the cardiovascular field.

The International Journal of Biomaterials, published by HINDAWI LTD, is a premier platform for disseminating groundbreaking research in the fields of biomaterials and biomedical engineering. With an Open Access approach since 2009, this journal provides unhindered access to innovative studies and applications aimed at advancing medical technologies and improving patient outcomes. Notably ranked in the Q3 category for both Biomaterials and Biomedical Engineering in 2023, it serves as an essential resource for researchers, practitioners, and students alike. The journal's Scopus rankings, including a 49th percentile in Biomedical Engineering and a 40th percentile in Biomaterials, further underscore its growing prominence in the academic community. With contributions spanning from 2011 to 2024, the journal seeks to foster collaborative research and promote developments that enhance the understanding and application of biomaterials in healthcare.

Biomedical Materials, published by IOP Publishing Ltd, is a premier journal dedicated to the rapidly evolving field of biomedical engineering and materials science. With a robust impact factor showcasing its influence, this journal serves as a vital platform for disseminating pioneering research from 2006 to 2024. Covering an array of interdisciplinary topics—ranging from biomaterials to bioengineering and applied chemistry—the journal consistently ranks in the second quartile across multiple categories including Bioengineering (Q2), Biomaterials (Q2), and Biomedical Engineering (Q2) as of 2023. Researchers, professionals, and students alike benefit from its contributions, exploring innovative solutions at the intersection of biology and material science. Although not an Open Access journal, Biomedical Materials remains essential in advancing our understanding and facilitating discussions surrounding state-of-the-art materials that revolutionize medical applications and enhance patient care.

Progress in Biomedical Engineering, published by IOP Publishing Ltd, is a premier open-access journal that serves as a vital platform for the dissemination of innovative research in the field of biomedical engineering. With an impressive Q1 classification in the Biomedical Engineering category for 2023, this journal has established itself as a significant contributor to the advancement of engineering solutions that improve healthcare outcomes. Recognized for its high-quality and impactful publications, it ranks 51st out of 303 in its field on Scopus, placing it in the 83rd percentile. The journal aims to foster interdisciplinary collaboration and introduce pioneering methodologies and technologies that bridge the gap between engineering and medicine. By providing a pathway for rapid communication of fundamental and applied research, Progress in Biomedical Engineering is dedicated to shaping the future of healthcare technology. Access to its content ensures that researchers, professionals, and students remain at the forefront of biomedical innovation.

Bio-Design and Manufacturing, published by SPRINGER HEIDELBERG, is a pioneering journal that stands at the forefront of innovation in the fields of Biomedical Engineering, Biotechnology, Industrial and Manufacturing Engineering, and Materials Science. With its ISSN 2096-5524 and E-ISSN 2522-8552, this journal has established itself as a leading platform for disseminating cutting-edge research and advancements that merge biological principles with manufacturing processes, emphasizing sustainable and efficient practices. It has garnered recognition in the 2023 category quartiles, boasting a Q1 rank in all its relevant fields, which underscores its significance and impact—evident from its prime Scopus rankings that place it within the top percentiles of numerous engineering and materials science disciplines. Researchers, professionals, and students alike benefit from the wealth of knowledge presented in this journal, making it an essential resource for those seeking to enhance their understanding of bio-design applications and innovation in manufacturing processes.

Advanced Biomedical Engineering is a peer-reviewed open access journal published by the Japanese Society for Medical & Biological Engineering, dedicated to disseminating high-quality research in the multidisciplinary fields of biomedical engineering. Boasting an ISSN of 2187-5219, this journal has been pivotal since its inception in 2018, especially as it embraces the open access model to foster knowledge sharing and wide accessibility. Centered in Tokyo, Japan, it serves as a vital platform for scholars and practitioners across various domains, such as biomaterials, biomedical engineering, and biotechnology. Despite currently residing in the Q4 quartile across several categories, including those in biotechnology and computer science applications, the journal is committed to elevating its academic impact and reputation, aiming for improved rankings in Scopus and other databases. Researchers and professionals are encouraged to contribute their innovative findings, discussions, and case studies, facilitating the advancement of this dynamic field.